Friday, December 12, 2025
11.9 C
London

Tag: immunotherapeutic

Immutep: Invests nearly $30M for ongoing clinical trials

Biotech company Immutep (IMM) has tapped institutional investors for a neat $29.6 million to fund its cancer and...